Economic impact of antimicrobial resistance.

McGowan, J. E.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Economic impact of antimicrobial resistance.

2001 Mar-Apr
By McGowan, J. E.
Source: Emerg Infect Dis. 7(2):286-292.

[PDF-66.32 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Emerg Infect Dis
Personal Author:

McGowan, J. E.
Description:

One reason antimicrobial-drug resistance is of concern is its economic impact on physicians, patients, health-care administrators, pharmaceutical producers, and the public. Measurement of cost and economic impact of programs to minimize antimicrobial-drug resistance is imprecise and incomplete. Studies to describe and evaluate the problem will have to employ new methods and be of large scale to produce information that is broadly applicable.
Subjects:

[+]

Drug Resistance, Microbial Health Care Costs Humans Public Health Public Opinion
Source:

Emerg Infect Dis. 7(2):286-292.
Document Type:

Journal Article
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

[+]

urn:sha256:bca860c1a882720a131ac6050de70b3009bd8908e19c140b540a830e0804be7b
Download URL:

https://stacks.cdc.gov/view/cdc/15101/cdc_15101_DS1.pdf
File Type:

	11294725.nxml	txt
	license.txt	txt

More +